Modulation and lack of cross-talk between signal transducer and activator of transcription 5 and suppressor of cytokine signaling-3 in insulin and growth hormone signaling in 3T3-L1 adipocytes

Obesity

Volumn 14, Issue 8, 2006, Pages 1303-1311

  Story, David J ^a   Stephens, Jacqueline M ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Adipocytes; Extracellular signal regulated kinases 1 and 2; Mitogenactivated protein kinase; Signal transducer and activator of transcription 5; Suppressor of cytokine signaling 3

Indexed keywords

1,3 BUTADIENE DERIVATIVE; 1,4 DIAMINO 1,4 BIS(2 AMINOPHENYLTHIO) 2,3 DICYANOBUTADIENE; CYCLOHEXIMIDE; ENZYME INHIBITOR; GLUCOSE; GROWTH HORMONE; INSULIN; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRILE; PROTEIN SYNTHESIS INHIBITOR; SOCS3 PROTEIN, MOUSE; STAT5 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN 3T3; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION; GENETICS; METABOLISM; MOUSE; NORTHERN BLOTTING; PHOSPHORYLATION; SIGNAL TRANSDUCTION; TIME; WESTERN BLOTTING;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; BLOTTING, NORTHERN; BLOTTING, WESTERN; BUTADIENES; CYCLOHEXIMIDE; ENZYME INHIBITORS; GENE EXPRESSION; GLUCOSE; GROWTH HORMONE; INSULIN; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; NITRILES; PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITORS; RNA, MESSENGER; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TIME FACTORS;

EID: 33750597368     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2006.148     Document Type: Article

References (35)

1. Saltiel AR, Kahn CR. Insulin signalling and the regulation of glucose and lipid metabolism. Nature. 2001;414:799-806.
2. Darnell JE Jr. STATs and gene regulation. Science. 1997:277:1630-5.
3. Krebs DL, Hilton DJ. SOCS: physiological suppressors of cytokine signaling. J Cell Sci. 2000;113:2813-9.
4. Chen J, Sadowski HB, Kohanski RA, Wang LH. Stat5 is a physiological substrate of the insulin receptor. Proc Natl Acad Sci U S A. 1997;94:2295-300.
5. Sawka-Verhelle D, Tartare-Deckert S, Decaux JF, Girard J, Van Obberghen E. Stat 5B, activated by insulin in a Jak-independent fashion, plays a role in glucokinase gene transcription. Endocrinology. 2000:141:1977-88.
6. Storz P, Doppler H, Horn-Muller J, Groner B, Pfizenmaier K, Muller G. A cellular reporter assay to monitor insulin receptor kinase activity based on STAT 5-dependent luciferase gene expression. Anal Biochem. 1999:276:97-104.
7. Emanuelli B, Peraldi P, Filloux C, Sawka-Verhelle D, Hilton D, Van Obberghen E. SOCS-3 is an insulin-induced negative regulator of insulin signaling. J Biol Chem. 2000;275:15985-91.
8. Peraldi P, Filloux C, Emanuelli B, Hilton DJ, Van Obberghen E. Insulin induces suppressor of cytokine signaling-3 tyrosine phosphorylation through janus-activated kinase. J Biol Chem. 2001;276:24614-20.
9. Senn JJ, Klover PJ, Nowak IA, et al. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes. J Biol Chem. 2003:278:13740-6.
10. Ueki K, Kondo T, Tseng YH, Kahn CR. Central role of suppressors of cytokine signaling proteins in hepatic steatosis, insulin resistance, and the metabolic syndrome in the mouse. Proc Natl Acad Sci USA. 2004:101:10422-7.
11. Shi H, Tzameli I, Bjorbaek C, Flier JS. Suppressor of cytokine signaling 3 is a physiological regulator of adipocyte insulin signaling. J Biol Chem. 2004;279:34733-40.
12. Shi H, Cave B, Inouye K, Bjorbaek C, Flier JS. Overexpression of suppressor of cytokine signaling 3 in adipose tissue causes local but not systemic insulin resistance. Diabetes. 2006;55:699-707.
13. Steppan CM, Wang J, Whiteman EL, Birnbaum MJ, Lazar MA. Activation of SOCS-3 by resistin. Mol Cell Biol. 2005;25:1569-75.
14. Mooney RA, Senn J, Cameron S, et al. Suppressors of cytokine signaling-1 and -6 associate with and inhibit the insulin receptor: a potential mechanism for cytokine-mediated insulin resistance. J Biol Chem. 2001;276:25889-93.
15. Balhoff JP, Stephens JM. Highly specific and quantitative activation of STATs in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 1998;247:894-900.
16. Herrington J, Carter-Su C. Signaling pathways activated by the growth hormone receptor. Trends Endocrinol Metab. 2001;12:252-7.
17. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680-5.
18. Stephens JM, Pekala PH. Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. J Biol Chem. 1991;266:21839-45.
19. Zvonic S, Story DJ, Stephens JM, Mynatt RL. Growth hormone, but not insulin, activates STAT5 proteins in adipocytes in vitro and in vivo. Biochem Biophys Res Commun. 2003:302:359-62.
20. Le MN, Kohanski RA, Wang LH, Sadowaski HB. Dual mechanisms of signal transducer and activator of transcription 5 activation by the insulin receptor. Mol Endocrinol. 2002:16:2764-79.
21. Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem. 2002:277:42394-8.
22. He F, Stephens JM. Induction of SOCS-3 is insufficient to confer IRS-1 protein degradation in 3T3-L1 adipocytes. Biochem Biophys Res Commun. 2006;344:95-8.
23. Bullen DV, Darwiche R, Metcalf D, Handman E, Alexander WS. Neutralization of interferon-gamma in neonatal SOCS1 -/- mice prevents fatty degeneration of the liver but not subsequent fatal inflammatory disease. Immunology. 2001:104:92-81.
24. Horvat S, Medrano JF. Lack of Socs2 expression causes the high-growth phenotype in mice. Genomics. 2001:72:209-12.
25. Marine JC, McKay C, Wang D, et al. SOCS3 is essential in the regulation of fetal liver erythropoiesis. Cell. 1999:98:617-27.
26. Roberts AW, Robb L, Rakar S, et al. Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci USA. 2001:98:9324-9.
27. Rizza RA, Mandarine LJ, Gerich JE. Effects of growth hormone on insulin action in man: mechanisms of insulin resistance, impaired suppression of glucose production, and impaired stimulation of glucose utilization. Diabetes. 1982;31:663-69.
28. Hansen I, Firth R, Raymond M, Cryer P, Rizza R. The role of autoregulation of the hepatic glucose production in man: response to a physiologic decrement in plasma glucose. Diabetes. 1986;35:186-91.
29. Smith TR, Elmendorf JS, David TS, Turinsky J. Growth hormone-induced insulin resistance: role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am J Physiol. 1997;272:E1071-9.
30. Thirone AC, Carvalho CR, Brenelli SL, Velloso LA, Saad MJ. Effect of chronic growth hormone treatment on insulin signal transduction in rat tissues. Mol Cell Endocrinol. 1997;130:33-42.
31. Dominici FP, Turyn D. Growth hormone-induced alterations in the insulin-signaling system. Exp Biol Med (Maywood). 2002;227:149-57.
32. van Kerkhof P, Strous GJ. The ubiquitin-proteasomepathway regulates lysosomal degradation of the growth hormone receptor and its ligand. Biochem Soc Trans. 2001;29:488-93.
33. Alves dos Santos CM, ten Broeke T, Strous GJ. Growth hormone receptor ubiquitination, endocytosis, and degradation are independent of signal transduction via Janus kinase 2. J Biol Chem. 2001;276:32635-41.
34. Rieusset J, Bouzakri K, Chevillotte E, et al. Suppressor of cytokine signaling 3 expression and insulin resistance in skeletal muscle of obese and type 2 diabetic patients. Diabetes. 2004:53:2232-41.
35. Jamshidi Y, Snieder H, Wang X, Spector TD, Carter ND, O'Dell SD. Common polymorphisms in SOCS-3 are not associated with body weight, insulin sensitivity or lipid profile in normal female twins. Diabetologia. 2006;49:306-10.